Atom | Breakthrough T1D Request for Applications: Advancing Genetic Risk Assessment for Type 1 Diabetes

Due Dates: May 13, 2025 (Webinar) | June 10, 2025 (Letter of Intent) | July 17, 2025 (Full Application)

Funding Amounts: Up to $900,000 total per award for up to 3 years; higher budgets considered with strong justification.

Summary: Supports research to improve genetic risk prediction and clinical translation for type 1 diabetes across diverse populations using advanced genetic risk scores.

Key Information: SRA-funded projects must join the T1D GRS Consortium; for-profit applicants should contact Breakthrough T1D before applying.

Breakthrough T1D Request for Applications: Advancing Genetic Risk Assessment for Type 1 Diabetes

Sign in to see full grant listing